| Financial Year |
March 31 2023 |
| Monetary Funds |
1,783,960,315.91 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
157,719,583.42 |
| Accounts Receivable |
354,205,790.77 |
| Advances to Suppliers |
23,392,994.07 |
| Other Receivables |
28,829,090.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
437,183,479.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
89,256,196.86 |
| Total Current Assets |
2,994,593,394.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,642,252.37 |
| Investment Properties |
4,064,948.40 |
| Fixed Assetes |
1,144,190,809.45 |
| Under-construction Projects |
1,298,865,048.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
387,642,798.45 |
| R&D expenses |
-- |
| Goodwill |
69,423,694.57 |
| Long-Term Deferred and Prepaid Expenses |
241,828.34 |
| Deferred Income Tax Assets |
12,849,956.92 |
| Other Non-Current Assets |
67,476,669.86 |
| Sub-Total of Non-Current Assets |
3,174,849,841.04 |
| Total Assets |
6,169,443,235.51 |
| Short-Term Loans |
244,295,009.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
315,224,070.69 |
| Accounts Payable |
525,670,905.65 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
34,347,447.64 |
| Taxes Payable |
12,933,908.60 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
177,749,962.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
93,366,621.37 |
| Other Current Liabilities |
1,004,468.01 |
| Sub-Total of Current Liabilities |
1,418,096,009.77 |
| Long-term Loans |
535,444,556.55 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,316,435.97 |
| Other Non-Current Liabilities |
31,301.09 |
| Sub-Total of Non-Current Liabilities |
682,525,179.19 |
| Total Liabilities |
2,100,621,188.96 |
| Paid-In Capital(Or Share Stock) |
589,578,593.00 |
| Capital Surplus |
1,707,713,525.46 |
| Surplus Reserve |
215,678,518.69 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,553,203,353.82 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,068,822,046.55 |
| Owner's Equity（Stockholder's Equity） |
4,068,822,046.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,169,443,235.51 |
